Logo Comparative Medicine Banner

Funded by a grant from the National Center for Research Resources (NCRR) (5P40RR003640),
National Institutes of Health



Virology Laboratory

HIV/SIV, HERPES and DENGUE related Publications

  1. Wojna V, Skolasky RL, McArthur JC, Maldonado E, Hechavarria R, Mayo R, Selnes O, Ginebra T, de la Torre T, García H, Kraiselburd E, Meléndez-Guerrero LM, Zorrilla CD, Nath A. Spanish validation of the HIV dementia scale in women. AIDS Patient Care STDS. 2007 Dec;21(12):930-41.

  2. Aidoo M, Otten RA, Rodriguez V, Sariol CA, Martinez M, Kraiselburd E, Robinson H, Folks T, Butera S, Ellenberger D. Absence of SHIV infection in gut and lymph node tissues in rhesus monkeys after repeated rectal challenges following HIV-1 DNA/MVA immunizations. Vaccine. 2007 Aug 29;25(35):6474-81. Epub 2007 Jun 29.

  3. Sariol, C.A., Arana, T., Gascot, S., Suárez, E., Maldonado, E. Gerald, M.S., Gonzalez-Martinez, J., Rodriguez, M., Kraiselburd, E.N. Transcriptional Activation Of Interferon Stimulated Genes But Not Of Cytokine Genes After Primary Infection Of Rhesus Macaques With Dengue Virus Type 1. Clin Vaccine Immunol. 2007 Apr 11

  4. Suárez E, Sariol CA, Burguete A, Mclachlan G. A tutorial in genetic epidemiology and some considerations in statistical modeling. P R Health Sci J. 2007 Dec;26(4):401-21.

  5. Ellenberger, D., Otten, R., Li, B., Aido, M., Rodriguez, I.V., Sariol, C.A., Martinez, M., Monsour, M., Wyatt, L., Hudgens, MG., Kraiselburd, E., Moss, B., Robinson, H., Folks, T., and Butera, S. HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges. Virology, 15;352(1):216-25,2006.

  6. Sariol, C.A., Arana, T., Gascot, S., Suárez, E., Maldonado, E. Gerald, M.S., Gonzalez-Martinez, J., Rodriguez, M., Kraiselburd, E.N. Differential Distribution of Antibodies to Different Viruses in the Free-Ranging Rhesus Macaques of Cayo Santiago. Medical Journal of Primatology. 35: 369-375, 2006.

  7. Wojna, V., Skolasky, R.L., Hechavarría, R., Mayo, R., Selnes, O., McArthur, J.C., Meléndez, L.M., Maldonado,E., Zorrilla,C.D., García, H., Kraiselburd,E., Nath, A., Avindra Nath. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. Journal of Neurovirology. Volume 12, Number 5, Pages: 356-364. October 2006.

  8. Ellenberger, D., Wyatt, L., Li, B., Buge, S., Lanier, N., Rodriguez, I.V., Sariol, C.A., Martinez, M., Monsour, M., Dowd, J., Smith, J., Otten, R., Montefiori, D., Kraiselburd, E., Moss, B., Robinson, H., McNicholl, J., and Butera, S. Comparative immunogenicity in rhesus monkeys of multi-protein 3 HIV-1 (CRF02_AG) DNA/MVA vaccines expressing 4 mature and immature VLPs. Virology, 340(1):21-32; Sep 15, 2005.

  9. Kumar, R., Perez-Casanova, A.E., Tirado, G., Noel, R.J., Torres, C., Rodriguez, I., Martinez, M., Staprans, S., Kraiselburd, E., Yamamura, Y., Higley, J.D., and Kumar, A. Increased viral replication in Simian Immunodeficiency Virus/Simian-HIV-Infected macaques with self-administering model of chronic alcohol consumption. J Acquir Immune Defic Syndr. Volume 39, Number 4, August 1, 2005.

  10. Sariol, C., Arana, T., Gerald, M.S., Maldonado, E., Gonzalez, J., Rodriguez, M., and Kraiselburd, E. Herpes-B virus seroreactivity in a colony of Macaca mulatta: Data from the Sabana Seca Field Station, a new Specific-Pathogen-Free Program. J Med Primatol; 34:13-19, 2005.

  11. Wojna V, Carlson KA, Luo X, Mayo R, Melendez LM, Kraiselburd, E., and Gendelman H.E. Proteomic fingerprinting of HIV-associated dementia from patient Monocyte-derived macrophages. A case study. Journal of Neurovirology. Volume 10, Supplement 1. (2004)

  12. Jensen, K., Alvarado-Remy, F., Gonzalez-Martinez, J., Kraiselburd, E., and Rullán, J. Herpesvirus B Outside of the Laboratory: B Virus and Free-Ranging Macaques, Puerto Rico. Emerging Infectious Diseases. Vol. 10, No. 3. March (2004)

  13. Eduardo O'Neill, Vanda Bostik, David C. Montefiori, Edmundo Kraiselburd, and François Villinger. IL- 12/GM-CFS Co-Administration In An SIV DNA Prime/Protein Boost Protocol Enhances Gag Specific T Cells But Not Virus-Specific Neutralizing Antibodies in Rhesus Macaques. AIDS Research and Human Retroviruses; Vol. 19, Num. 10, October 2003.

  14. O'Neill E, Martinez I, Villinger F, Rivera M, Gascot S, Colon C, Arana T, Sidhu M, Stout R, Montefiori DC, Martinez M, Ansari AA, Israel ZR, Kraiselburd E. Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration. J Med Primatol. 2002 Aug;31(4-5):217-27.

  15. Martinez L, Giavedoni L, Kraiselburd E. Clone B7 cells have a single copy of SIVsmB7 integrated in chromosome 20. Arch Virol. 2002;147(1):217-23.

  16. Kraiselburd EN, Salaman A, Beltran M, Rivera M, Oliver J, Kessler M, Knezevich M, Rodriguez A, Bilska M, Montefiori D, Torres-Bauza LJ, Martinez I. Vaccine evaluation studies of replication-defective SIVsmB7. Cell Mol Biol. 1997 Nov;43(7):915-24.

  17. Kraiselburd EN, Torres JV. Properties of virus-like particles produced by SIV-chronically infected human cell clones. Cell Mol Biol. 1995;41 Suppl 1:S41-52.




Valid CSS! Valid XHTML 1.0!